In anaplastic thyroid cancer, NSUN2 regulates SRSF6 splicing to enhance UAP1 and ABC transporter function, inducing multidrug resistance reversible by NSUN2 targeting [282]. This evidence concerns the gene NSUN2 and thyroid gland undifferentiated (anaplastic) carcinoma.